Related Experiment Video
Updated: Dec 9, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Symptomatic pericardial effusion in the setting of asymptomatic COVID-19 infection: A case report
Behzad Amoozgar1,2, Varun Kaushal1, Umair Mubashar1
1Department of Internal Medicine, Jersey Shore University Medical Center, Perth Amboy Division.
Insights
Severe acute respiratory syndrome coronavirus disease 2019 (COVID-19) can cause pericardial effusion, even in asymptomatic cases. Early diagnosis and intervention are crucial for preventing severe outcomes like cardiac tamponade.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- COVID-19 infection can lead to multi-organ involvement, including inflammation of the cardiopulmonary serosal layers.
- Pericarditis and pericardial effusion are potential complications of COVID-19, sometimes occurring without typical respiratory symptoms.
Observation:
- A rare case of pericardial effusion in an asymptomatic patient with COVID-19 presenting with chest pain is described.
- Initial COVID-19 diagnostic tests (RT-PCR) were negative, but subsequent testing and serology confirmed the infection, suggesting reinfection or a subacute presentation.
Findings:
- Echocardiography revealed a large circumferential pericardial effusion with mild pericardial thickening.
- The patient successfully underwent a pericardial window procedure and medical management, leading to complete resolution of the effusion upon follow-up.
Implications:
- Clinicians should maintain a high index of suspicion for pericardial effusion in patients with unexplained chest pain, even with negative initial COVID-19 tests.
- Prompt diagnosis and management of COVID-19-associated pericardial effusion are essential to prevent serious complications such as cardiac tamponade.
Rationale:
Infection with the severe acute respiratory coronavirus disease 2019 (COVID-19) has been shown to cause multi-organ involvement including cardiopulmonary serosal layers infection and inflammation. As a result, pericarditis and pericardial effusion may occur with or without COVID-19 related respiratory signs. Due to limitations in sensitivity and specificity of current COVID-19 diagnostic studies, cases that trigger high clinical intuition, even with negative serologic and polymerase chain reaction testing results, may necessitate further diagnostic workup to discover the underlying etiology.
Patient Concerns:
Here we present a rare case of pericardial effusion in the setting of asymptomatic COVID-19 infection manifesting with the chief complaint of chest pain.
Diagnosis:
While undergoing diagnostic workup, the patients first 2 sets of COVID 19 reverse transcription-polymerase chain reaction (RT-PCR) were negative while a latter RT-PCR test, as well as serology, were positive, leading to the diagnosis of COVID-19 reinfection or subacute presentation of viral infection with pericardial effusion. Echocardiogram depicted large circumferential pericardial effusion with mildly thickened pericardium.
Interventions:
The patient underwent pericardial window placement followed by ibuprofen administration and discharged from the hospital.
Outcomes:
During the follow-up visit patient had no symptoms and echocardiogram demonstrated complete resolution of the effusion.
Lessons:
Due to the possible establishment of pericardial effusions and consecutively tamponade even without any COVID-19 related clinical presentation, it is crucial for clinicians to trust their intuition, conduct the appropriate diagnostic tests, find the underlying diagnosis and prevent the devastating consequences.
Related Concept Videos
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis I: Introduction
Pericarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis IV: Nursing Management
